Northern Trust
CGEM icon

Northern Trust’s Cullinan Oncology CGEM Stock Holding History

Northern Trust’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
571,080
+121,822
+27% +$1.81M ﹤0.01% 2198
2026
Q1 		$6.38M Buy
449,258
+27,623
+7% +$355K ﹤0.01% 2334
2025
Q4 		$4.36M Sell
421,635
-25,632
-6% -$231K ﹤0.01% 2552
2025
Q3 		$2.65M Sell
447,267
-5,936
-1% -$43.5K ﹤0.01% 2877
2025
Q2 		$3.41M Sell
453,203
-30,686
-6% -$247K ﹤0.01% 2697
2025
Q1 		$3.66M Sell
483,889
-17,019
-3% -$163K ﹤0.01% 2589
2024
Q4 		$6.1M Buy
500,908
+30,023
+6% +$432K ﹤0.01% 2395
2024
Q3 		$7.88M Buy
470,885
+174,033
+59% +$3.09M ﹤0.01% 2203
2024
Q2 		$5.18M Buy
296,852
+32,903
+12% +$701K ﹤0.01% 2377
2024
Q1 		$4.5M Sell
263,949
-2,973
-1% -$45.9K ﹤0.01% 2533
2023
Q4 		$2.72M Buy
266,922
+12,105
+5% +$107K ﹤0.01% 2824
2023
Q3 		$2.31M Buy
254,817
+18,279
+8% +$190K ﹤0.01% 2864
2023
Q2 		$2.55M Sell
236,538
-12,040
-5% -$128K ﹤0.01% 2872
2023
Q1 		$2.54M Sell
248,578
-40,557
-14% -$447K ﹤0.01% 2832
2022
Q4 		$3.05M Buy
289,135
+15,152
+6% +$184K ﹤0.01% 2768
2022
Q3 		$3.51M Buy
273,983
+4,706
+2% +$63.4K ﹤0.01% 2703
2022
Q2 		$3.45M Buy
269,277
+30,334
+13% +$344K ﹤0.01% 2744
2022
Q1 		$2.5M Buy
238,943
+7,560
+3% +$102K ﹤0.01% 2984
2021
Q4 		$3.57M Buy
231,383
+2,380
+1% +$47.5K ﹤0.01% 2902
2021
Q3 		$5.17M Buy
229,003
+96,629
+73% +$2.58M ﹤0.01% 2712
2021
Q2 		$3.41M Sell
132,374
-8,866
-6% -$273K ﹤0.01% 3066
2021
Q1 		$5.88M Buy
+141,240
New +$5.73M ﹤0.01% 2652

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Northern Trust's CGEM Position: Q2 2026 in Review

Northern Trust increased its Cullinan Oncology (CGEM) stake by 27% in Q2 2026, buying an estimated $1.81M and bringing the position to 571,080 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Northern Trust first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Northern Trust held 571,080 shares of Cullinan Oncology worth $10.4M as of Q2 2026.
  • Northern Trust bought 121,822 Cullinan Oncology shares in Q2 2026, an estimated $1.81M.
  • Cullinan Oncology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2198 holding.
  • Northern Trust first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.